Background-It
D
obutamine stress echocardiography (DSE) is a wellestablished stress imaging test commonly used to detect myocardial ischemia and coronary artery disease (CAD). In the presence of flow-limiting CAD, dobutamine induces transient impairment of regional ventricular function. These changes are observable with echocardiographic imaging. [1] [2] [3] Although it is often assumed that patients who have positive DSE findings in the setting of a hypertensive response during the test are more likely to have false-positive test results, this assumption is not supported by published data. In fact, unlike for exercise echocardiography, [4] [5] [6] no studies exist on the relationship between BP response and positive DSE results. Studies on the clinical implications of a hypotensive response during DSE included small numbers of patients and did not compare echocardiographic findings with those of coronary angiography. [7] [8] [9] Whether hypertensive or hypotensive responses during DSE are more or less likely to be associated with abnormal DSE findings is unclear, and whether such findings are associated with obstructive CAD has not been systematically studied. We sought to define the impact of abnormal blood pressure (BP) responses during DSE on the results of the stress test and to establish the frequency of false-positive DSE results in patients undergoing clinically indicated coronary angiography.
Methods

Study Population
A total of 24 134 patients underwent DSE at Mayo Clinic, Rochester, MN, from November 2003 to December 2012. The study was approved by an institutional review committee, and the subjects gave informed consent for their data to be used for research purposes. Excluded were patients who did not give permission (n=521) and patients who had at least moderate valvular heart disease (n=952), dilated cardiomyopathy (n=203), missing data (n=445), or uninterpretable tests (n=64). After these exclusions, the study population comprised 21 949 patients. These were grouped according to the peak systolic BP (SBP) achieved during DSE, using recently published cut point values obtained from 2968 patients without known cardiovascular disease and not on vasoactive medications. 10 A history of CAD was defined as a history of myocardial infarction, previous percutaneous coronary revascularization, or previous coronary artery bypass graft surgery.
DSE Protocol
After a 3-hour fast, dobutamine was administered intravenously by an infusion pump at a starting dose of 5 μg·kg −1 ·min −1 . After 3 minutes, the dose was increased to 10 μg·kg −1 ·min −1 and then by 10 μg·kg −1 ·min −1 every 3 minutes, up to a maximal dose of 40 μg·kg −1 ·min −1 if needed. Intravenous atropine was administered to patients who did not achieve their target heart rate (HR), which was 85% of age-predicted maximal HR. 11 Atropine was administrated in 0.25 mg dose increments every 1 minute, up to a maximum of 2 mg if necessary. 12 The criteria for terminating the test were those recommended by practice guidelines 1, 11 and included SBP >240 mm Hg or diastolic BP (DBP) >120 mm Hg and symptomatic hypotension. The stress ECG was considered positive for ischemia if there was ≥1 mm horizontal or downsloping STsegment depression at 80 ms after the J-point. 13 SBP and DBP measurements were made at baseline and every 3 minutes during the test, near or at peak stress, and in recovery. Hypertensive BP response was defined by peak SBP >182 mm Hg and hypotensive response by peak SBP <82 mm Hg.
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Stress Echocardiography
Two-dimensional digitized and videotaped echocardiographic images were acquired at baseline, throughout the stress test, and during recovery by sonographers and analyzed by level 3-trained echocardiologists. 14 The left ventricular (LV) ejection fraction was determined at baseline and at peak stress by visual assessment or by a modification of the Quinones method. 15 The overall change in LV end-systolic volume (LVESV) was assessed visually by comparing baseline and peak stress digitized images side by side. The LVESV response was considered normal if the LVESV decreased and abnormal if it increased or did not change appreciably. 16 A 16-segment LV model 11 was used for semiquantitative scoring at baseline and at peak stress. The segments were scored according to guideline recommendations. 11 The LV wall motion score index was calculated by adding the scores then dividing by 16. Patients with normal DSE results had normal LV regional and global systolic function at baseline and no stress-induced wall motion abnormalities (WMA). Patients with abnormal DSE results had WMA at baseline or stress-induced WMA. Abnormal DSE results were subclassified as follows: patients who had WMA at baseline that were unchanged with stress had a fixed abnormality; patients who had WMA at baseline and who developed new or worsening WMA with stress had a mixed abnormality; and patients who had no WMA at baseline and new WMA with stress had an ischemic abnormality. 16 Patients who had DSE results that were positive for ischemia were those with a mixed or an ischemic abnormality. Patients with abnormal findings were also stratified according to the extent of abnormality with stress. Abnormal and ischemic segments were counted for each patient: 1 to 2 segments defined a mild abnormality; 3 to 4 segments a moderate abnormality; and ≥5 segments (>25% of LV segments) an extensive abnormality. 16 Microbubble contrast agents were used in 11 331 patients (51%) to improve endocardial border definition.
Coronary Angiography
Coronary angiography was performed for clinical reasons within 30 days after DSE in a subgroup and interpreted by experienced invasive cardiologists. 17 The definition of normal coronary arteries was the absence of luminal irregularities or any other CAD in any of the epicardial vessels. Mild, nonobstructive CAD was defined by the presence of <50% diameter stenosis and obstructive CAD by ≥50% stenosis in 1 or more coronary arteries or major coronary branches. Severe CAD was defined by ≥70% stenosis. The definition of severe multivessel CAD was ≥50% left main stenosis or ≥70% stenosis of 2 or 3 vessels. Angiograms were categorized with the Duke CAD Prognostic Index tool. 18 Each patient was assigned a score ranging from 0 to 100 based on the extent and severity of their CAD. For CAD severity categorization, a 70% stenosis cut point was used instead of 75% and 90% instead of 95%. For patients with previous coronary artery bypass graft surgery, the Duke Graft Index was used. 19 Graft disease was defined by ≥70% stenosis. The CAD prognostic index was compared with wall motion score index at peak stress according to peak SBP attained.
Statistical Analysis
Clinical, echocardiographic, and angiographic data were summarized using means and SDs for continuous variables and percentages for dichotomous or qualitative variables. T tests, χ 2 tests, and ANOVA were used when appropriate. The hypertensive and hypotensive response groups were separately compared with the normal BP response group (reference group). Paired sample t test and ANOVA for paired data were used to compare intragroup differences. A significance level of 0.05 was considered statistically significant. We built logistic regression models, including all baseline characteristics of patients, to define predictors of hypertensive and hypotensive responses during DSE.
Positive DSE tests were defined as true positives when obstructive CAD was found at coronary angiography and false positives when there was no stenosis or if it was <50%. Positive predictive values (PPVs) were calculated by dividing the number of true positives by the sum of true positives and false positives. Analyses were performed using JMP, version 10.0.0 (SAS Institute, Inc, Cary, NC). DSE data were also presented in graphic form, stratified by peak SBP attained in increments of 20 mm Hg for the whole study population and for the subgroup who underwent coronary angiography.
Results
Of the 21 949 patients, 19 770 patients (90%) had a normal BP response during DSE, 1905 patients (9%) had a hypertensive response, and 274 patients (1%) had a hypotensive response. Characteristics of the study population are shown in Table 1 . 
Predictors of Abnormal BP Responses During DSE
Stress Echocardiogram Results
The proportion of positive (mixed+ischemic) DSE test results was significantly greater among patients who had a hypertensive response compared with those with a normal BP response (32% versus 21%; P<0.0001). The proportion of positive DSE tests began to increase at a peak SBP of 160 mm Hg (Figure 1 ). We observed a similar trend when we stratified DSE results by ∆SBP increments and by peak DBP (data not shown). Patients with a hypertensive response were more likely to have extensive echocardiographic abnormalities at peak stress, including lower ejection fraction, abnormal LVESV response, and more abnormal and ischemic LV segments (Table 2 ; Figure 2) . The proportion of positive DSE test results was similar for patients with a hypotensive response and those with a normal BP response (23% versus 21%; P=0.4; Table 2 ).
Coronary Angiography Results
Of the 4740 patients with a positive DSE, 1126 patients (24%) underwent coronary angiography within 30 days after DSE. Of these, 814 patients (72%) had obstructive CAD (≥50% stenosis): 106 patients (9%) had 50% to 69% stenosis, and 708 patients (63%) had ≥70% stenosis; 228 patients (20%) had mild, nonobstructive CAD (<50% stenosis) and 84 patients (8%) had no CAD.
Peak SBP values achieved during DSE were available for 1117 patients. Of these, 902 patients (81%) had a normal BP response, 206 patients (18%) had a hypertensive response, and only 9 patients (1%) had a hypotensive response. Coronary angiography results, stratified by 20 mm Hg increments of peak SBP during DSE, are shown in Figure 2 .
Most patients with a hypertensive response had obstructive CAD. The proportion of positive coronary angiographic results was similar for these patients and those who had a normal BP response (PPV 69% versus 73%; P=0.3; Table  3 ). Patients with a hypertensive response, however, were less likely to have severe CAD (≥70% stenosis) compared with those who had a normal BP response (54% versus 65%; P<0.005). This was most apparent at a peak SBP ≥220 mm Hg (57% of patients with peak SBP between 200 and 219 mm Hg versus 40% of patients with SBP ≥220 mm Hg; P=0.07; Figure 2 ). The presence of severe CAD (≥70% stenosis) was independently associated with a hypertensive response (OR, 0.64; CI, 0.45-0.9; P=0.012) in a multivariate model adjusted for age, sex, rest SBP, rest HR, β-blocker therapy, and calcium channel blocker therapy. Patients with higher peak SBPs were more likely to have extensive ischemia compared with those who had a normal BP response (Figure 3) . Likewise, there was a discordant relationship between the wall motion score index at peak stress and the extent and severity of CAD as summarized by the Duke CAD prognostic index; at higher peak SBPs, the wall motion score index increased, and the extent and severity of CAD decreased (Figure 4 ). Patients with a hypertensive response were less likely to have severe multivessel CAD compared with those who had a normal BP response (34% versus 42%; P=0.03). A similar proportion had previously undergone coronary artery bypass graft surgery (16% versus 13%; P=0.46), but a greater percentage of bypass grafts were patent in patients with a hypertensive response compared with those who had a normal BP response (63 of 77 grafts, 81% versus 186 of 282 grafts, 65%; Continuous data are expressed as mean±SD and categorical data as n (%). ACE-i indicates angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blocker; BP, blood pressure; CAD, coronary artery disease; DBP, diastolic blood pressure; HR, heart rate; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; SBP, systolic blood pressure; and WMSI, wall motion score index. *P<0.0001. †P<0.05 compared with normal BP response group.
P=0.01).
Only nine patients had a hypotensive response. Of these, 3 patients had no CAD, 3 had nonobstructive CAD, 1 had 50% to 69% stenosis, and 2 had ≥70% stenosis.
Patients Without a History of CAD
To minimize the potentially confounding effect of the presence of known CAD, we examined the subgroup of 16 387 patients who did not have a history of CAD. Findings were similar to those of the whole study population; the DSE results were more likely to be positive as the peak SBP increased, beginning at 160 mm Hg. In the angiographic subgroup (n=675), the PPV of the test was 60%; this value was similar for patients who had a hypertensive response and those who did not. Patients with a hypertensive response were less likely to have severe CAD at coronary angiography.
Patients With Markedly Abnormal LV Contractile Reserve
A total of 410 patients in the angiographic subgroup had an abnormal LVESV response; 220 of 275 patients (80%) who had a normal BP response and 99 of 135 patients (73%) who had a hypertensive response had obstructive CAD (P=0.13).
The proportion of patients with severe CAD tended to be lower in patients who had a hypertensive response compared with those who had a normal BP response (57% versus 76%; P<0.0001). Of patients who had a peak SBP ≥220 mm Hg, neither a multivariate nor a univariate predictor of a false-positive DSE result.
Discussion
We have demonstrated that a hypertensive response during DSE is not an uncommon finding and is associated with a higher frequency of positive test results compared with a normal BP response without being associated with a higher likelihood of false-positive test results. At angiography, the likelihood of finding obstructive CAD (≥50% stenosis) is not different for the 2 groups. However, patients with a hypertensive response are less likely to have severe CAD (≥70% stenosis).
Hypertensive Response During DSE
In this study population, a hypertensive response during DSE occurred in 9% of patients and was more often seen in younger patients, men, and those with hypertension and diabetes mellitus. Additionally, patients with a hypertensive response were more likely to be on β-blocker therapy and to receive atropine during DSE. Several mechanisms likely contributed to the development of a hypertensive response during DSE. Dobutamine, a synthetic catecholamine, increases myocardial oxygen consumption through mostly inotropic and chronotropic effects. Its predominant mechanism of action is agonism of cardiac β-1-adrenergic receptors. It has weaker effects on the peripheral vasculature from opposing effects of β-2-adrenergic and α-1-adrenergic receptor agonism. In our previous study, performed on a relatively healthy cohort, we demonstrated that although the BP response during DSE is variable, there is typically a slight increase in SBP and a decrease in DBP during dobutamine stress. 10 The presence of hypertension, diabetes mellitus, atherosclerotic cardiovascular disease, and the use of vasoactive medications can alter the physiological cardiovascular response to adrenergic stimulation, resulting in different BP responses, both systolic and diastolic. For example, patients with hypertension or diabetes mellitus often have elevated peripheral vascular resistance; an increase in cardiac output by dobutamine may not be offset by prompt peripheral vasodilation in some of these patients. 20 The modest vasoconstrictive effects of dobutamine may be exaggerated in hypertensive patients who have sympathetic nervous system hypersensitivity. Additionally, β-blocker therapy can inhibit or attenuate any vasodilatory effects of dobutamine. 21 Atropine, a parasympatholytic agent, exerts its effects by competitive antagonism of muscarinic acetylcholine receptors at the cardiac level, thereby increasing cardiac output. 22 Atropine administration may, thus, contribute to a hypertensive response during DSE.
Implications of a Hypertensive Response
Although data are lacking in the literature on the PPV of DSE in patients with abnormal BP responses during the test, a positive DSE result during a hypertensive response is often considered to be false positive in clinical practice. However, our novel observations demonstrate that patients with positive DSE and a hypertensive response during the test are just as likely to have obstructive CAD as patients with a normal BP response. The observation that patients with a hypertensive response are less likely to have severe CAD, however, suggests that an acute increase in afterload, which is part of the hypertensive response during DSE, plays a role in the development of transient abnormalities of LV systolic function in susceptible patients. This mechanism most likely explains the discordance between the severity of ischemic echocardiographic changes and the extent and severity of CAD at higher peak SBPs (Figure 4 ). Other mechanisms, not detectable by coronary angiography, may cause stressinduced myocardial ischemia in these patients. These include microvascular CAD, abnormal coronary flow reserve and coronary vasospasm, and possibly myocardial bridging and early LV myopathy. 23, 24 Other factors, such as regional heterogeneity of myocardial thickening, can occasionally lead to overinterpretation of WMA.
Hypotensive Response During DSE
Several mechanisms have been described to explain the occurrence of a hypotensive response during DSE: dynamic intraventricular obstruction, poor LV systolic function, vagal reflex, or dobutamine-induced vasodilatation. 9, 25 Unlike what has been previously demonstrated in the context of exercise stress testing, 26 the association between a hypotensive response during DSE and the positivity of the test for inducible ischemia has not been found. 7, 25, 27 In the present study, the proportion of positive DSE results was similar in patients with hypotensive and normal BP responses, as was the severity of the echocardiographic ischemic changes in the 2 groups. These results suggest that the hypotensive response during DSE is not because of LV ischemic systolic dysfunction. Conversely, another recent study 9 found a greater proportion of inducible ischemia in patients with a hypotensive response during DSE. However, the population included in that study had poor LV systolic function at baseline, worse than that of patients in the current study.
Limitations
This was a retrospective observational study; patient data were entered into a research database at the time of stress testing. The decision to proceed with coronary angiography, although based on the stress echocardiographic findings, was ultimately made by the referring physician and the patient after consideration of several factors. Only 24% of patients who had DSE findings positive for ischemia underwent angiography. Because of this post-test referral bias, which is a consequence of clinical practice, we did not attempt to calculate the sensitivity, specificity, or diagnostic accuracy of DSE. We calculated the PPV of the stress test and acknowledge that the PPV is not immune to test-verification bias either. Twenty-five echocardiologists, all level 3 trained, were involved in reviewing and interpreting this large number of clinically indicated DSEs during the 9-year time period. The potential impact of interobserver variability on this study's findings is unknown.
Conclusions
A hypertensive response during DSE, in comparison to a normal BP response, is associated with a higher frequency of positive DSE tests without being associated with a higher likelihood of false-positive results. However, severe CAD is less likely to be present in patients with a hypertensive response during DSE compared with those who have a normal BP response. 
